{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:47:54Z","timestamp":1791132474019,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T00:00:00Z","timestamp":1346112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T00:00:00Z","timestamp":1346112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/leu.2012.247","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T06:43:21Z","timestamp":1346136201000},"page":"569-577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia"],"prefix":"10.1038","volume":"27","author":[{"given":"K","family":"Morrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C P","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Raber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Del Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Wilk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Wyczechowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P C","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,28]]},"reference":[{"key":"BFleu2012247_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1365-2141.2011.08847.x","volume":"156","author":"H Inaba","year":"2012","unstructured":"Inaba H, Bhojwani D, Pauley JL, Pei D, Cheng C, Metzger ML et al. Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies. Br J Haematol 2012; 156: 275\u2013279.","journal-title":"Br J Haematol"},{"key":"BFleu2012247_CR2","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1182\/blood-2004-04-1616","volume":"104","author":"CH Pui","year":"2004","unstructured":"Pui CH, Sandlund JT, Pei D, Campana D, Rivera GK, Ribeiro RC et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children\u2019s Research Hospital. Blood 2004; 104: 2690\u20132696.","journal-title":"Blood"},{"key":"BFleu2012247_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1586\/ehm.10.73","volume":"3","author":"R Tanosaki","year":"2010","unstructured":"Tanosaki R, Tobinai K . Adult T-cell leukemia-lymphoma: current treatment strategies and novel immunological approaches. Expert Rev Hematol 2010; 3: 743\u2013753.","journal-title":"Expert Rev Hematol"},{"key":"BFleu2012247_CR4","first-page":"70","volume":"24","author":"GF Laport","year":"1997","unstructured":"Laport GF, Larson RA . Treatment of adult acute lymphoblastic leukemia. Semin Oncol 1997; 24: 70\u201382.","journal-title":"Semin Oncol"},{"key":"BFleu2012247_CR5","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1182\/blood-2009-12-258822","volume":"115","author":"CP Hernandez","year":"2010","unstructured":"Hernandez CP, Morrow K, Lopez-Barcons LA, Zabaleta J, Sierra R, Velasco C et al. Pegylated arginase I: a potential therapeutic approach in T-ALL. Blood 2010; 115: 5214\u20135221.","journal-title":"Blood"},{"key":"BFleu2012247_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nrm1618","volume":"6","author":"M Holcik","year":"2005","unstructured":"Holcik M, Sonenberg N . Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 2005; 6: 318\u2013327.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFleu2012247_CR7","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/ncb1996","volume":"11","author":"CW Woo","year":"2009","unstructured":"Woo CW, Cui D, Arellano J, Dorweiler B, Harding H, Fitzgerald KA et al. Adaptive suppression of the ATF4-CHOP branch of the unfolded protein response by toll-like receptor signalling. Nat Cell Biol 2009; 11: 1473\u20131480.","journal-title":"Nat Cell Biol"},{"key":"BFleu2012247_CR8","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1126\/science.1175678","volume":"324","author":"JM Blander","year":"2009","unstructured":"Blander JM, Amsen D . Immunology. amino acid addiction. Science 2009; 324: 1282\u20131283.","journal-title":"Science"},{"key":"BFleu2012247_CR9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1083\/jcb.200308075","volume":"163","author":"C Jousse","year":"2003","unstructured":"Jousse C, Oyadomari S, Novoa I, Lu P, Zhang Y, Harding HP et al. Inhibition of a constitutive translation initiation factor 2alpha phosphatase, CReP, promotes survival of stressed cells. J Cell Biol 2003; 163: 767\u2013775.","journal-title":"J Cell Biol"},{"key":"BFleu2012247_CR10","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1083\/jcb.153.5.1011","volume":"153","author":"I Novoa","year":"2001","unstructured":"Novoa I, Zeng H, Harding HP, Ron D . Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J Cell Biol 2001; 153: 1011\u20131022.","journal-title":"J Cell Biol"},{"key":"BFleu2012247_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1182\/blood-2006-08-039883","volume":"110","author":"SM Chan","year":"2007","unstructured":"Chan SM, Weng AP, Tibshirani R, Aster JC, Utz PJ . Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood 2007; 110: 278\u2013286.","journal-title":"Blood"},{"key":"BFleu2012247_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris JP, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269\u2013271.","journal-title":"Science"},{"key":"BFleu2012247_CR13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/genetics\/154.2.787","volume":"154","author":"R Sood","year":"2000","unstructured":"Sood R, Porter AC, Olsen DA, Cavener DR, Wek RC . A mammalian homologue of GCN2 protein kinase important for translational control by phosphorylation of eukaryotic initiation factor-2alpha. Genetics 2000; 154: 787\u2013801.","journal-title":"Genetics"},{"key":"BFleu2012247_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1158\/0008-5472.CAN-06-1945","volume":"67","author":"PN Cheng","year":"2007","unstructured":"Cheng PN, Lam TL, Lam WM, Tsui SM, Cheng AW, Lo WH et al. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. Cancer Res 2007; 67: 309\u2013317.","journal-title":"Cancer Res"},{"key":"BFleu2012247_CR15","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1091\/mbc.e10-01-0023","volume":"21","author":"H Muaddi","year":"2010","unstructured":"Muaddi H, Majumder M, Peidis P, Papadakis AI, Holcik M, Scheuner D et al. Phosphorylation of eIF2alpha at serine 51 is an important determinant of cell survival and adaptation to glucose deficiency. Mol Biol Cell 2010; 21: 3220\u20133231.","journal-title":"Mol Biol Cell"},{"key":"BFleu2012247_CR16","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1182\/blood-2006-06-031856","volume":"109","author":"PC Rodriguez","year":"2007","unstructured":"Rodriguez PC, Quiceno DG, Ochoa AC . L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 2007; 109: 1568\u20131573.","journal-title":"Blood"},{"key":"BFleu2012247_CR17","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1158\/0008-5472.CAN-08-1921","volume":"69","author":"PC Rodriguez","year":"2009","unstructured":"Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 2009; 69: 1553\u20131560.","journal-title":"Cancer Res"},{"key":"BFleu2012247_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.bbrc.2003.07.020","volume":"313","author":"C Jousse","year":"2004","unstructured":"Jousse C, Averous J, Bruhat A, Carraro V, Mordier S, Fafournoux P . Amino acids as regulators of gene expression: molecular mechanisms. Biochem Biophys Res Commun 2004; 313: 447\u2013452.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFleu2012247_CR19","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1126\/science.1101902","volume":"307","author":"M Boyce","year":"2005","unstructured":"Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner D et al. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 2005; 307: 935\u2013939.","journal-title":"Science"},{"key":"BFleu2012247_CR20","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1200\/JCO.2004.11.120","volume":"22","author":"F Izzo","year":"2004","unstructured":"Izzo F, Marra P, Beneduce G, Castello G, Vallone P, De R V et al. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I\/II studies. J Clin Oncol 2004; 22: 1815\u20131822.","journal-title":"J Clin Oncol"},{"key":"BFleu2012247_CR21","doi-asserted-by":"publisher","first-page":"7660","DOI":"10.1200\/JCO.2005.02.0933","volume":"23","author":"PA Ascierto","year":"2005","unstructured":"Ascierto PA, Scala S, Castello G, Daponte A, Simeone E, Ottaiano A et al. Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. J Clin Oncol 2005; 23: 7660\u20137668.","journal-title":"J Clin Oncol"},{"key":"BFleu2012247_CR22","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.1182\/blood-2010-06-287839","volume":"116","author":"SL Highfill","year":"2010","unstructured":"Highfill SL, Rodriguez PC, Zhou Q, Goetz CA, Koehn BH, Veenstra R et al. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 2010; 116: 5738\u20135747.","journal-title":"Blood"},{"key":"BFleu2012247_CR23","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1101\/gad.891101","volume":"15","author":"CU Hellen","year":"2001","unstructured":"Hellen CU, Sarnow P . Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev 2001; 15: 1593\u20131612.","journal-title":"Genes Dev"},{"key":"BFleu2012247_CR24","doi-asserted-by":"publisher","first-page":"8238","DOI":"10.1128\/MCB.21.23.8238-8246.2001","volume":"21","author":"R Schneider","year":"2001","unstructured":"Schneider R, Agol VI, Andino R, Bayard F, Cavener DR, Chappell SA et al. New ways of initiating translation in eukaryotes. Mol Cell Biol 2001; 21: 8238\u20138246.","journal-title":"Mol Cell Biol"},{"key":"BFleu2012247_CR25","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/jn\/136.6.1466","volume":"136","author":"J Talvas","year":"2006","unstructured":"Talvas J, Obled A, Fafournoux P, Mordier S . Regulation of protein synthesis by leucine starvation involves distinct mechanisms in mouse C2C12 myoblasts and myotubes. J Nutr 2006; 136: 1466\u20131471.","journal-title":"J Nutr"},{"key":"BFleu2012247_CR26","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1158\/0008-5472.CAN-08-3858","volume":"69","author":"DM Schewe","year":"2009","unstructured":"Schewe DM, guirre-Ghiso JA . Inhibition of eIF2alpha dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy. Cancer Res 2009; 69: 1545\u20131552.","journal-title":"Cancer Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2012247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012247","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:46:33Z","timestamp":1648741593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2012247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,28]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["BFleu2012247"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.247","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,28]]},"assertion":[{"value":"11 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}